Financing - December 19, 2019
Calliditas announces first milestone payment from Everest Medicines
Calliditas Therapeutics has announced that a $5 million milestone payment from its partner Everest Medicines II Limited has been triggered as per the licensing agreement under which Everest is to develop and commercialize Calliditas’ leading drug candidate Nefecon in Greater China and Singapore. The National Medical Products Administration (NMPA, formerly known as CFDA) has approved […]
Financing - December 19, 2019
Nordic Nanovector awarded NOK 12 million in funding from the Norwegian Research Council
Nordic Nanovector’s research and development project Nanoyield has received a non-dilutive funding of NOK 12 million (USD 1.3 million) from the Norwegian Research Council (Forskningsrådet). The Nanoyield project is aimed at optimising the production yield of Nordic Nanovector’s CD37-targeting antibody NNV003. The NNV003 antibody is the antibody component of the radioimmunoconjugate Alpha37. The project will […]
Financing - December 12, 2019
Gedea Biotech awarded €3 million by EU’s Horizon 2020
Swedish women’s health company Gedea Biotech has been awarded €3 million by EU’s Horizon 2020 to accelerate introduction of antibiotic-free treatment for vaginal infections. Gedea Biotech has announced that it has received €3 million from the EU program Fast Track to Innovation (FTI), part of Horizon 2020. The grant will fund completion of the clinical […]
Financing - December 11, 2019
“Solid science and syndication”
Petri Laine is Managing Partner at Innovestor Ventures, a venture capital arm of Innovestor Group. He has been working with high-growth companies for 20 years and prior to joining Innovestor he built Finland’s largest venture portfolio covering all fields of technology, making 200+ investments over a period of 10 years. What kind of companies are you […]
Financing - December 10, 2019
“Don’t delay your fundraising process”
Ingrid Teigland Akay is Managing Partner at Hadean Ventures, a life science fund manager that invests in life science companies across Europe, with a particular focus on the Nordic region. What kind of companies are you and your colleagues focusing your investments on? And what stages? “Hadean Ventures is a Nordics-focused, European life science VC […]
CDMO - December 10, 2019
Recipharm invests in its US inhalation development service
Recipharm has invested USD 450,000 into its Research Triangle Park (RTP), North Carolina, US facility to install a SprayVIEW system that will support inhalation and nasal product development. The newly acquired system was installed alongside an environmental controlled aerosol collection chamber for inhalation testing and a metered dose inhaler (MDI) and dry powder inhaler (DPI) […]
